Novonix (NVX) Payables (2020 - 2025)

Novonix (NVX) has 6 years of Payables data on file, last reported at $75.4 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 87.57% year-over-year to $75.4 million; the trailing twelve-month figure through Dec 2025 stood at $75.4 million (up 87.57% YoY), and the FY2025 full-year result was $75.4 million, up 87.57% from the prior year.
• Payables for Q4 2025 stood at $75.4 million, up from $40.2 million in the prior quarter.
• Across five years, Payables topped out at $75.4 million in Q4 2025 and bottomed at $3.6 million in Q2 2021.
• The 5-year median for Payables is $6.8 million (2022), against an average of $22.8 million.
• The widest annual swing landed in 2023, when Payables dropped 4.72%; it then surged 506.56% in 2024.
• A 5-year view of Payables shows it stood at $3.6 million in 2021, then soared by 94.9% to $7.0 million in 2022, then decreased by 4.72% to $6.6 million in 2023, then soared by 506.56% to $40.2 million in 2024, then jumped by 87.57% to $75.4 million in 2025.
• The last three Payables figures came in at $75.4 million (Q4 2025), $40.2 million (Q4 2024), and $6.6 million (Q4 2023), per Business Quant data.

Peer Comparison